Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm

PHASE2CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

March 27, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Paroxysmal Supraventricular Tachycardia (PSVT)
Interventions
DRUG

Etripamil

intranasal administration via 4 prefilled Aptar Pharma Unit-Dose Spray devices

DRUG

Placebo

intranasal administration via 4 prefilled Aptar Pharma Unit-Dose Spray devices

Trial Locations (30)

20010

Medstar Washington Hospital Center, Washington D.C.

21237

MedStar Health Research Institute, Baltimore

22908

University of Virginia Medical Center, Charlottesville

23507

Sentara Norfolk General Hospital, Norfolk

24501

Centra Stroobants Cardiovascular Center, Lynchburg

30309

Piedmont Atlanta Hospital, Atlanta

30322

Emory University Hospital, Atlanta

32216

Memorial Hospital Jacksonville, Jacksonville

32224

Mayo Clinic Jacksonville, Jacksonville

33606

University of South Florida Health South Tampa Center, Tampa

33709

Northside Hospital, St. Petersburg

43606

ProMedica Toledo Hospital, Toledo

44094

Great Lakes Medical Research, LLC, Willoughby

44708

Aultman Hospital Cardiology Clinical Trials, Canton

45267

University of Cincinnati Medical Center Division of Cardiovascular Diseases, Cincinnati

50266

Iowa Heart Center, West Des Moines

55902

Mayo Clinic, Rochester

57701

Black Hills Cardiovascular Research, Rapid City

66160

University of Kansas Medical Center, Kansas City

77030

Baylor St. Luke's Hospital, Houston

Houston Methodist Hospital, Houston

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

80120

South Denver Cardiology Associates, Littleton

85013

Arizona Heart Rhythm Center, Phoenix

85054

Mayo Clinic Arizona, Phoenix

95819

Mercy General Hospital, Sacramento

M4N 3M5

Sunnybrook Health Sciences Center, Toronto

M5B 1W8

St. Michael's Hospital, Toronto

H1T 1C8

The Montreal Heart Institute, Montreal

H2W 1T8

CHUM Hotel Dieu, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medpace, Inc.

INDUSTRY

lead

Milestone Pharmaceuticals Inc.

OTHER